JULIUS MINGRONI: Open Payments
NPI 1669485751 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 11 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $69 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $46 |
| Exact Sciences Corporation | 2 | $43 |
| Alkermes, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
Products named: SHINGRIX, Cologuard Collection Kit, VIVITROL, IBSRELA, CREON, MOUNJARO, TREMFYA, Korlym.
Industry payments across NJ — which companies pay providers there.
